CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-25 | PAULSON & CO. INC. 10% owner | Purchase | +2,500,000 | $6.25 | $15.6M | 73,255,869 |
| 2025-08-14 | Paulson John Director | Purchase | +34,721,118 | $9.00 | $312.5M | 70,755,869 |
| 2025-08-13 | Paulson John Director | Purchase | +86,409 | $7.06 | $610K | 36,034,751 |
| 2025-08-12 | Paulson John Director | Purchase | +1,156,640 | $6.88 | $8.0M | 35,948,342 |
| 2025-08-11 | Paulson John Director | Purchase | +2,000,000 | $6.35 | $12.7M | 34,791,702 |
| 2025-06-13 | Paulson John Director | Purchase | +3,564,059 | $5.94 | $21.2M | 32,791,702 |
| 2025-06-12 | Paulson John Director | Purchase | +1,005,376 | $5.47 | $5.5M | 29,227,643 |
| 2025-06-11 | Paulson John Director | Purchase | +1,029,098 | $5.24 | $5.4M | 28,222,267 |
| 2025-06-10 | Paulson John Director | Purchase | +754,134 | $5.05 | $3.8M | 27,193,169 |
Page 1 of 1 · 9 trades